Compartir
array:24 [
"pii" => "S0213911104718191"
"issn" => "02139111"
"doi" => "10.1016/S0213-9111(04)71819-1"
"estado" => "S300"
"fechaPublicacion" => "2004-03-01"
"aid" => "71819"
"copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
"copyrightAnyo" => "2004"
"documento" => "article"
"crossmark" => 0
"licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
"subdocumento" => "fla"
"cita" => "Gac Sanit. 2004;18:137-44"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 2945
"formatos" => array:3 [
"EPUB" => 100
"HTML" => 2410
"PDF" => 435
]
]
"itemSiguiente" => array:19 [
"pii" => "S0213911104718208"
"issn" => "02139111"
"doi" => "10.1016/S0213-9111(04)71820-8"
"estado" => "S300"
"fechaPublicacion" => "2004-03-01"
"aid" => "71820"
"copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
"documento" => "article"
"crossmark" => 0
"licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
"subdocumento" => "fla"
"cita" => "Gac Sanit. 2004;18:145-9"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 3174
"formatos" => array:3 [
"EPUB" => 122
"HTML" => 2656
"PDF" => 396
]
]
"es" => array:10 [
"idiomaDefecto" => true
"titulo" => "Características epidemiológicas de las nuevas infecciones causadas por el VIH comparadas con los casos de sida. La epidemia de VIH/sida en el País Vasco"
"tienePdf" => "es"
"tieneTextoCompleto" => 0
"tieneResumen" => array:2 [
0 => "es"
1 => "en"
]
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "145"
"paginaFinal" => "149"
]
]
"titulosAlternativos" => array:1 [
"en" => array:1 [
"titulo" => "Epidemiological characteristics of new HIV infections compared with AIDS cases. The HIV/AIDS epidemic in the Basque Country [Spain]"
]
]
"contieneResumen" => array:2 [
"es" => true
"en" => true
]
"contienePdf" => array:1 [
"es" => true
]
"autores" => array:2 [
0 => array:2 [
"autoresLista" => "Francisco Javier Rodríguez"
"autores" => array:1 [
0 => array:2 [
"nombre" => "Francisco"
"apellidos" => "Javier Rodríguez"
]
]
]
1 => array:2 [
"autoresLista" => "Daniel Zulaika, Koldo Agirrebengoa, Ander Andía, Julio Arrizabalaga, José María Bustillo, Mari Mar Cámara, Jesús Corral, Mari Carmen Orive, Julio Goikoetxea, José Antonio Iribarren, Josefina López de Munain, José Manuel Lorenzo, María José Martín Gudino, Eduardo Martínez, José Mayo, Joseba Portu, Rafael Silvariño, Zuriña Zubero"
"autores" => array:19 [
0 => array:2 [
"nombre" => "Daniel"
"apellidos" => "Zulaika"
]
1 => array:2 [
"nombre" => "Koldo"
"apellidos" => "Agirrebengoa"
]
2 => array:2 [
"nombre" => "Ander"
"apellidos" => "Andía"
]
3 => array:2 [
"nombre" => "Julio"
"apellidos" => "Arrizabalaga"
]
4 => array:2 [
"nombre" => "José"
"apellidos" => "María Bustillo"
]
5 => array:2 [
"nombre" => "Mari"
"apellidos" => "Mar Cámara"
]
6 => array:2 [
"nombre" => "Jesús"
"apellidos" => "Corral"
]
7 => array:2 [
"nombre" => "Mari"
"apellidos" => "Carmen Orive"
]
8 => array:2 [
"nombre" => "Julio"
"apellidos" => "Goikoetxea"
]
9 => array:2 [
"nombre" => "José"
"apellidos" => "Antonio Iribarren"
]
10 => array:2 [
"nombre" => "Josefina"
"apellidos" => "López de Munain"
]
11 => array:2 [
"nombre" => "José"
"apellidos" => "Manuel Lorenzo"
]
12 => array:2 [
"nombre" => "María"
"apellidos" => "José Martín Gudino"
]
13 => array:2 [
"nombre" => "Eduardo"
"apellidos" => "Martínez"
]
14 => array:2 [
"nombre" => "José"
"apellidos" => "Mayo"
]
15 => array:2 [
"nombre" => "Joseba"
"apellidos" => "Portu"
]
16 => array:2 [
"nombre" => "Rafael"
"apellidos" => "Silvariño"
]
17 => array:2 [
"nombre" => "Zuriña"
"apellidos" => "Zubero"
]
18 => array:1 [
"colaborador" => "por el Grupo de Trabajo para el Estudio de la Infección por el VIH en el País Vasco"
]
]
]
]
]
"idiomaDefecto" => "es"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911104718208?idApp=WGSE"
"url" => "/02139111/0000001800000002/v1_201310251548/S0213911104718208/v1_201310251548/es/main.assets"
]
"itemAnterior" => array:19 [
"pii" => "S021391110471818X"
"issn" => "02139111"
"doi" => "10.1016/S0213-9111(04)71818-X"
"estado" => "S300"
"fechaPublicacion" => "2004-03-01"
"aid" => "71818"
"copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
"documento" => "article"
"crossmark" => 0
"licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
"subdocumento" => "sco"
"cita" => "Gac Sanit. 2004;18:136"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 2435
"formatos" => array:3 [
"EPUB" => 100
"HTML" => 1901
"PDF" => 434
]
]
"es" => array:8 [
"idiomaDefecto" => true
"titulo" => "Camus y el principio de precaución"
"tienePdf" => "es"
"tieneTextoCompleto" => 0
"paginas" => array:1 [
0 => array:1 [
"paginaInicial" => "136"
]
]
"titulosAlternativos" => array:1 [
"en" => array:1 [
"titulo" => "Camus and the precautionary principle"
]
]
"contienePdf" => array:1 [
"es" => true
]
"autores" => array:1 [
0 => array:2 [
"autoresLista" => "Ana M. García"
"autores" => array:1 [
0 => array:2 [
"nombre" => "Ana M."
"apellidos" => "García"
]
]
]
]
]
"idiomaDefecto" => "es"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021391110471818X?idApp=WGSE"
"url" => "/02139111/0000001800000002/v1_201310251548/S021391110471818X/v1_201310251548/es/main.assets"
]
"es" => array:14 [
"idiomaDefecto" => true
"titulo" => "«A propósito de un caso». ¿Sirven los genéricos para moderar el gasto en hipertensión?"
"tieneTextoCompleto" => 0
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "137"
"paginaFinal" => "144"
]
]
"autores" => array:1 [
0 => array:4 [
"autoresLista" => "Antonio J. García, Francisco Martos, Ángel Martín, Felipe Sánchez"
"autores" => array:4 [
0 => array:4 [
"nombre" => "Antonio J."
"apellidos" => "García"
"email" => array:1 [
0 => "ajgr@uma.es"
]
"referencia" => array:3 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">a</span>"
"identificador" => "aff0005"
]
1 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">b</span>"
"identificador" => "aff0010"
]
2 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">*</span>"
"identificador" => "cor0005"
]
]
]
1 => array:3 [
"nombre" => "Francisco"
"apellidos" => "Martos"
"referencia" => array:2 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">a</span>"
"identificador" => "aff0005"
]
1 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">b</span>"
"identificador" => "aff0010"
]
]
]
2 => array:3 [
"nombre" => "Ángel"
"apellidos" => "Martín"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">c</span>"
"identificador" => "aff0015"
]
]
]
3 => array:3 [
"nombre" => "Felipe"
"apellidos" => "Sánchez"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">b</span>"
"identificador" => "aff0010"
]
]
]
]
"afiliaciones" => array:3 [
0 => array:3 [
"entidad" => "<span class="elsevierStyleItalic">Unidad de Farmacoeconomía e Investigación de Resultados en Salud. Universidad de Málaga. Málaga</span>"
"etiqueta" => "a"
"identificador" => "aff0005"
]
1 => array:3 [
"entidad" => "<span class="elsevierStyleItalic">Departamento de Farmacología y Terapéutica Clínica. Universidad de Málaga. Málaga</span>"
"etiqueta" => "b"
"identificador" => "aff0010"
]
2 => array:3 [
"entidad" => "<span class="elsevierStyleItalic">Centro de Información del Medicamento. Ilustre Colegio Oficial de Farmacéuticos de Málaga. España</span>"
"etiqueta" => "c"
"identificador" => "aff0015"
]
]
"correspondencia" => array:1 [
0 => array:3 [
"identificador" => "cor0005"
"etiqueta" => "*"
"correspondencia" => "Correspondencia: Unidad de Farmacoeconomía e IRS. Departamento de Farmacología. Facultad de Medicina. Universidad de Málaga. 29071 Málaga. España."
]
]
]
]
"titulosAlternativos" => array:1 [
"en" => array:1 [
"titulo" => "«Apropos of a case»: do generic drugs help control expenditure on hypertension?"
]
]
"pdfFichero" => "main.pdf"
"tienePdf" => true
"fechaRecibido" => "2003-06-10"
"fechaAceptado" => "2003-11-18"
"PalabrasClave" => array:2 [
"es" => array:1 [
0 => array:4 [
"clase" => "keyword"
"titulo" => "Palabras clave"
"identificador" => "xpalclavsec268653"
"palabras" => array:7 [
0 => "Medicamentos genéricos"
1 => "Gasto farmacéutico"
2 => "Utilización"
3 => "IECA"
4 => "ARA II"
5 => "Farmacoeconomía"
6 => "Economía de la salud"
]
]
]
"en" => array:1 [
0 => array:4 [
"clase" => "keyword"
"titulo" => "Key words"
"identificador" => "xpalclavsec268654"
"palabras" => array:7 [
0 => "Generic drugs"
1 => "Pharmaceutical expenditure"
2 => "Drug utilization"
3 => "ACEi"
4 => "ARB"
5 => "Pharmacoeconomics"
6 => "Health economics"
]
]
]
]
"tieneResumen" => true
"resumen" => array:2 [
"es" => array:2 [
"titulo" => "Resumen"
"resumen" => "<span class="elsevierStyleSectionTitle">Objetivo</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Se analiza desde la perspectiva del pagador (Sistema Nacional de Salud [SNS]) la influencia que tienen los genéricos en el gasto en medicamentos en la hipertensión arterial, examinándose el subgrupo terapéutico de mayor consumo y utilización, los inhibidores de la enzima de conversión de la angiotensina (IECA) y antagonistas de los receptores de la angiotensina II (ARA II).</p> <span class="elsevierStyleSectionTitle">Métodos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Partiendo de los datos de facturación al SNS de todas las oficinas de farmacia del Área de Salud de Málaga, se explora el consumo (envases y gasto) de los fármacos IECA, IECA + especialidades farmacéuticas genéricas (EFG) y ARA II, desde 1999 hasta 2002, así como el precio medio (ponderando según ventas) y el porcentaje de desviación de prescripción de un grupo a otro.</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">El incremento en envases del subgrupo C09 fue del 20,79%, muy superior para los ARA II (136%) y los IECA + EFG (177%). El gasto total creció en más del 42%. Se redujo el gusto en IECA en casi el 7%, a pesar del incremento en gasto de los IECA + EFG, mientras que los ARA II lo aumentaron en más del 154%. El precio medio ponderado según las ventas de este subgrupo terapéutico se incrementó en cerca del 18%. Se produjo un descenso en el precio medio ponderado de los principios activos donde había EFG (captopril y enalapril) además de otros (trandolapril), pero entre los ARA II destaca el aumento en el precio medio ponderado según las ventas de irbesartán (9%) y valsartán (16%).</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Los genéricos usados han originado una disminución en el gasto de IECA y del precio medio ponderado del subgrupo. Pero a pesar del incesante aumento en el consumo de las especialidades farmacéuticas genéricas, no se ha producido el efecto ahorrador pretendido con este tipo de medicamentos por el Ministerio de Sanidad y Consumo. Se apunta como posible causa la desviación de las prescripciones hacia los medicamentos no afectados de sustitución por parte de la oficina de farmacia.</p>"
]
"en" => array:2 [
"titulo" => "Abstract"
"resumen" => "<span class="elsevierStyleSectionTitle">Objetive</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">In this article we analyze the influence of generic drugs on pharmaceutical expenditure on hypertension from the payer’s perspective (the public health service), by examining the most widely used drugs: angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARBs).</p> <span class="elsevierStyleSectionTitle">Methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Based on billing data to the public health service from all the pharmacies in the Health Area of Malaga, we studied the utilization (containers and cost) of ACEi (generic drugs –ACEi+G– and brand name) and ARBs (brand name only) (subgroup C09 – ATC index) from 1999 to 2002. The mean price (weighted according to sales) and the percentage of deviation of prescriptions from one group of drugs to another was also studied.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">The increase in consumption of packages in subgroup C09 was 20.79%; the increase was greater for ARBs (136%) and for ACEi+G (177%). The total amount spent during the study period increased by more than 42%. Expenditure on ACEis decreased by almost 7%, despite the increase in expenditure on ACEi+G, whereas expenditure on ARBs increased by more than 154%. The mean price of this subgroup, weighted according to sales, increased by nearly 18%. The mean weighted price of the generic drugs, captopril and enalapril, and that of the brand name, trandolapril, decreased. Notable among ARBs was the increase in mean price weighted according to sales of irbesartan (9%) and valsartan (16%).</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">The use of generic drugs has reduced expenditure on ACEi and the mean weighted price of the subgroup. However, the increased use of generic drugs has not produced the expected savings for the Department of Health. This could be due to deviation of prescription scores toward drugs not affected by substitution by the pharmacy.</p>"
]
]
"bibliografia" => array:2 [
"titulo" => "Bibliografía"
"seccion" => array:1 [
0 => array:2 [
"identificador" => "bibs0005"
"bibliografiaReferencia" => array:33 [
0 => array:3 [
"identificador" => "bib0005"
"etiqueta" => "1."
"referencia" => array:1 [
0 => array:1 [
"host" => array:1 [
0 => array:1 [
"Libro" => array:4 [
"titulo" => "Dirección General de Farmacia y Productos Sanitarios"
"fecha" => "2003"
"editorial" => "Ministerio de Sanidad y Consumo"
"editorialLocalizacion" => "Madrid"
]
]
]
]
]
]
1 => array:3 [
"identificador" => "bib0010"
"etiqueta" => "2."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Hipertensión arterial en España"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "H. Pardell"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Libro" => array:3 [
"edicion" => "2<span class="elsevierStyleSup">a</span>"
"titulo" => "Liga Española para la Lucha contra la Hipertensión Arterial"
"fecha" => "1986"
]
]
]
]
]
]
2 => array:3 [
"identificador" => "bib0015"
"etiqueta" => "3."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Estudio epidemiológico andaluz sobre factores de riesgo cardiovascular. Estudio Al-Andalus 90"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:2 [
0 => "P. Aranda"
1 => "J. Villar"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Libro" => array:4 [
"titulo" => "Grupo colaborativo Andaluz sobre factores de riesgo cardiovascular"
"fecha" => "1993"
"editorial" => "Junta de Andalucía, Consejería de Sanidad"
"editorialLocalizacion" => "Sevilla"
]
]
]
]
]
]
3 => array:3 [
"identificador" => "bib0020"
"etiqueta" => "4."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "La hipertensión arterial en España"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:2 [
0 => "J. Muñiz"
1 => "R. Juane"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Rev Esp Cardiol"
"fecha" => "1995"
"volumen" => "48"
"paginaInicial" => "3"
"paginaFinal" => "8"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/8775805"
"web" => "Medline"
]
]
]
]
]
]
]
]
4 => array:3 [
"identificador" => "bib0025"
"etiqueta" => "5."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Sistema Nacional de Salud durante 1999 Información Terapéutica del"
"autores" => array:1 [
0 => array:2 [
"colaboracion" => "Grupos terapéuticos y principios activos de mayor consumo en el"
"etal" => false
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Sistema Nacional de Salud"
"fecha" => "2000"
"volumen" => "24"
"paginaInicial" => "73"
"paginaFinal" => "76"
]
]
]
]
]
]
5 => array:3 [
"identificador" => "bib0030"
"etiqueta" => "6."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Nacional de Salud durante 2000"
"autores" => array:1 [
0 => array:2 [
"colaboracion" => "Grupos terapéuticos y principios activos de mayor consumo en el Sistema"
"etal" => false
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Información Terapéutica del Sistema Nacional de Salud"
"fecha" => "2001"
"volumen" => "25"
"paginaInicial" => "78"
"paginaFinal" => "82"
]
]
]
]
]
]
6 => array:3 [
"identificador" => "bib0035"
"etiqueta" => "7."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Sistema Nacional de Salud durante 2001"
"autores" => array:1 [
0 => array:2 [
"colaboracion" => "Grupos terapéuticos y principios activos de mayor consumo en el"
"etal" => false
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Información Terapéutica del Sistema Nacional de Salud"
"fecha" => "2002"
"volumen" => "26"
"numero" => "3"
"paginaInicial" => "78"
"paginaFinal" => "83"
]
]
]
]
]
]
7 => array:3 [
"identificador" => "bib0040"
"etiqueta" => "8."
"referencia" => array:1 [
0 => array:1 [
"referenciaCompleta" => "Clasificación Anatómica Terapéutica. ATC Index [consultado 6/05/2003]. Disponible en: <a class="elsevierStyleInterRef" href="http://www.whocc.no/atcddd/indexdatabase/9">http://www.whocc.no/atcddd/indexdatabase/9</a>. Ley 13/1996, de Medidas Fiscales, Administrativas y de Orden Social. Capítulo III. Acción administrativa en materia educativa y sanitaria. Artículo 169. Modificación de la Ley 25/1990, de 20 de diciembre, del medicamento"
]
]
]
8 => array:3 [
"identificador" => "bib0045"
"etiqueta" => "10."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:6 [
0 => "A. Dollar"
1 => "C. Brown"
2 => "D. Putnam"
3 => "T. McLaughlin"
4 => "L. Okamoto"
5 => "R. Arocho"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Clin Ther"
"fecha" => "2002"
"volumen" => "24"
"paginaInicial" => "930"
"paginaFinal" => "941"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12117083"
"web" => "Medline"
]
]
]
]
]
]
]
]
9 => array:3 [
"identificador" => "bib0050"
"etiqueta" => "11."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Current recommendations for the treatment of hypertension: are they still valid?"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "M. Moser"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "J Hypertens"
"fecha" => "2002"
"volumen" => "20"
"paginaInicial" => "3"
"paginaFinal" => "10"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/11791019"
"web" => "Medline"
]
]
]
]
]
]
]
]
10 => array:3 [
"identificador" => "bib0055"
"etiqueta" => "12."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "O.O. Akinboboye"
1 => "R.L. Chou"
2 => "S.R. Bergmann"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "J Am Coll Cardiol"
"fecha" => "2002"
"volumen" => "40"
"paginaInicial" => "703"
"paginaFinal" => "709"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12204500"
"web" => "Medline"
]
]
]
]
]
]
]
]
11 => array:3 [
"identificador" => "bib0060"
"etiqueta" => "13."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Case 3: a patient with systemic hypertension and left ventricular hypertrophy"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:2 [
0 => "R.A. Kloner"
1 => "V.E. Friedewald Jr."
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Am J Cardiol"
"fecha" => "2000"
"volumen" => "85"
"paginaInicial" => "522"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/10728968"
"web" => "Medline"
]
]
]
]
]
]
]
]
12 => array:3 [
"identificador" => "bib0065"
"etiqueta" => "14."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "L. Tylicki"
1 => "P. Rutkowski"
2 => "M. Renke"
3 => "B. Rutkowski"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "65227"
"Revista" => array:6 [
"tituloSerie" => "Am J Nephrol"
"fecha" => "2002"
"volumen" => "22"
"paginaInicial" => "356"
"paginaFinal" => "362"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12169868"
"web" => "Medline"
]
]
]
]
]
]
]
]
13 => array:3 [
"identificador" => "bib0070"
"etiqueta" => "15."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "A. Ahmed"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "J Am Geriatr Soc"
"fecha" => "2002"
"volumen" => "50"
"paginaInicial" => "1297"
"paginaFinal" => "1300"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12133029"
"web" => "Medline"
]
]
]
]
]
]
]
]
14 => array:3 [
"identificador" => "bib0075"
"etiqueta" => "16."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:5 [
0 => "C. Delles"
1 => "J. Jacobi"
2 => "S. John"
3 => "I. Fleischmann"
4 => "R.E. Schmieder"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1046/j.1523-1755.2002.00260.x"
"Revista" => array:6 [
"tituloSerie" => "Kidney Int"
"fecha" => "2002"
"volumen" => "61"
"paginaInicial" => "1462"
"paginaFinal" => "1468"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/11918753"
"web" => "Medline"
]
]
]
]
]
]
]
]
15 => array:3 [
"identificador" => "bib0080"
"etiqueta" => "17."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitus"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "R.A. Preston"
1 => "N.M. Baltodano"
2 => "A.B. Alonso"
3 => "M. Epstein"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "J Clin Pharmacol"
"fecha" => "2002"
"volumen" => "42"
"paginaInicial" => "754"
"paginaFinal" => "761"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12092742"
"web" => "Medline"
]
]
]
]
]
]
]
]
16 => array:3 [
"identificador" => "bib0085"
"etiqueta" => "18."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "T. Nakamura"
1 => "C. Ushiyama"
2 => "S. Suzuki"
3 => "M. Hara"
4 => "N. Shimada"
5 => "K. Sekizuka"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "13619"
"Revista" => array:6 [
"tituloSerie" => "Am J Nephrol"
"fecha" => "2000"
"volumen" => "20"
"paginaInicial" => "373"
"paginaFinal" => "379"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/11092994"
"web" => "Medline"
]
]
]
]
]
]
]
]
17 => array:3 [
"identificador" => "bib0090"
"etiqueta" => "19."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:5 [
0 => "M. Guazzi"
1 => "P. Palermo"
2 => "G. Pontone"
3 => "F. Susini"
4 => "P. Agostoni"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Am J Cardiol"
"fecha" => "1999"
"volumen" => "84"
"paginaInicial" => "1038"
"paginaFinal" => "1043"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/10569660"
"web" => "Medline"
]
]
]
]
]
]
]
]
18 => array:3 [
"identificador" => "bib0095"
"etiqueta" => "20."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of Elite-2"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "C. Berry"
1 => "J. Norrie"
2 => "J.V. McMurray"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Am J Cardiol"
"fecha" => "2001"
"volumen" => "87"
"paginaInicial" => "606"
"paginaFinal" => "607"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/11230847"
"web" => "Medline"
]
]
]
]
]
]
]
]
19 => array:3 [
"identificador" => "bib0100"
"etiqueta" => "21."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "The role of angiotensin II receptor blockers in the treatment of heart failure patients"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "M. Theal"
1 => "C. Memers"
2 => "R.S. McKelvie"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Cogest Heart Fail"
"fecha" => "2003"
"volumen" => "9"
"paginaInicial" => "29"
"paginaFinal" => "34"
]
]
]
]
]
]
20 => array:3 [
"identificador" => "bib0105"
"etiqueta" => "22."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Clinical trials of angiotensin receptor blockers in heart failure: what do we know and what will we learn?"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "B. Pitt"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Am J Hypertens"
"fecha" => "2002"
"volumen" => "15"
"paginaInicial" => "22"
"paginaFinal" => "27"
]
]
]
]
]
]
21 => array:3 [
"identificador" => "bib0110"
"etiqueta" => "23."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "ACE inhibitors and ARBs in chronic heart failure: the established, the expected, and the pragmatic"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "P.A. Poole-Wilson"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Med Clin North Am"
"fecha" => "2003"
"volumen" => "87"
"paginaInicial" => "373"
"paginaFinal" => "389"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12693730"
"web" => "Medline"
]
]
]
]
]
]
]
]
22 => array:3 [
"identificador" => "bib0115"
"etiqueta" => "24."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "ACE inhibitors vs ARBs: is one class better for heart failure?"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:2 [
0 => "M.E. Dunlap"
1 => "R.C. Peterson"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Cleve Clin J Med"
"fecha" => "2002"
"volumen" => "69"
"paginaInicial" => "433"
"paginaFinal" => "438"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12022388"
"web" => "Medline"
]
]
]
]
]
]
]
]
23 => array:3 [
"identificador" => "bib0120"
"etiqueta" => "25."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Are angiotensin II receptor blokers more efficacious than placebo in heart failure? Implications of ELITE-2"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "C. Berry"
1 => "J. Norrie"
2 => "J.V. McMurray"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Am J Cardiol"
"fecha" => "2001"
"volumen" => "87"
"paginaInicial" => "606"
"paginaFinal" => "607"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/11230847"
"web" => "Medline"
]
]
]
]
]
]
]
]
24 => array:3 [
"identificador" => "bib0125"
"etiqueta" => "26."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:1 [
"titulo" => "Prescrire Rèdaction. Indications et choix des anthypertenseurs (suite)"
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:4 [
"tituloSerie" => "Rev Prescr"
"fecha" => "2000"
"volumen" => "20"
"paginaInicial" => "220"
]
]
]
]
]
]
25 => array:3 [
"identificador" => "bib0130"
"etiqueta" => "27."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Angiotensin II receptor blockers: clinical relevance and therapeutics role"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:2 [
0 => "J.E. Rodgers"
1 => "J.H. Patterson"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Am J Health Syst Pharm"
"fecha" => "2001"
"volumen" => "58"
"paginaInicial" => "671"
"paginaFinal" => "683"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/11329759"
"web" => "Medline"
]
]
]
]
]
]
]
]
26 => array:3 [
"identificador" => "bib0135"
"etiqueta" => "28."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Genéricos: ¿buenos o malos? Conocimientos y actitudes de los médicos ante los medicamentos genéricos"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "A.J. García"
1 => "F. Martos"
2 => "F. Leiva"
3 => "F. Sánchez de la Cuesta"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Gac Sanit"
"fecha" => "2003"
"volumen" => "2"
"paginaInicial" => "144"
"paginaFinal" => "149"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/3148583"
"web" => "Medline"
]
]
]
]
]
]
]
]
27 => array:3 [
"identificador" => "bib0140"
"etiqueta" => "29."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:1 [
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "C. Malo de Molina"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Libro" => array:2 [
"titulo" => "Encuesta Nacional sobre genéricos. Sigma Dos. Presentada en la 5.<span class="elsevierStyleSup">a</span> Jornada Nacional «Los genéricos hoy»"
"fecha" => "2003"
]
]
]
]
]
]
28 => array:3 [
"identificador" => "bib0145"
"etiqueta" => "30."
"referencia" => array:1 [
0 => array:1 [
"referenciaCompleta" => "Acuerdo sobre la prescripción por principio activo [consultado 26/05/2003]. Disponible en: [<a class="elsevierStyleInterRef" href="http://www.juntadeandalucia.es/servicioandaluzdesalud/publicaciones/sasinfo11/DATOS/SASINFO/otras_4.html">http://www.juntadeandalucia.es/servicioandaluzdesalud/publicaciones/sasinfo11/DATOS/SASINFO/otras_4.html</a>"
]
]
]
29 => array:3 [
"identificador" => "bib0150"
"etiqueta" => "31."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Simulación económica sobre la aplicación desarrollo de la OM y RD de precios de referencia"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "A.J. García Ruiz"
1 => "F. Martos"
2 => "E. Blanco"
3 => "F. Sánchez de la Cuesta"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:2 [
"tituloSerie" => "Libro de Ponencias de las XXII Jornadas de la Asociación de Economía de la Salud"
"fecha" => "2002"
]
]
]
]
]
]
30 => array:3 [
"identificador" => "bib0155"
"etiqueta" => "32."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:1 [
"titulo" => "Los genéricos en la OCDE"
]
]
"host" => array:1 [
0 => array:1 [
"Libro" => array:2 [
"titulo" => "Informe del National Economics Research Associates (NERA)"
"fecha" => "1998"
]
]
]
]
]
]
31 => array:3 [
"identificador" => "bib0160"
"etiqueta" => "33."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "La cultura del genérico no se debe implantar a golpe de Real Decreto [entrevista]"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "F. Sánchez de la Cuesta"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "OMC, Revista del Consejo General de Colegios Médicos de España"
"fecha" => "1999"
"volumen" => "63"
"paginaInicial" => "14"
"paginaFinal" => "16"
]
]
]
]
]
]
32 => array:3 [
"identificador" => "bib0165"
"etiqueta" => "34."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Declaración de la Comisión Central de Deontología sobre la Ética de la Prescripción y Sustitución de Medicamentos Genéricos"
"autores" => array:1 [
0 => array:2 [
"colaboracion" => "Organización Médica Colegial (OMC)"
"etal" => false
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:4 [
"tituloSerie" => "Aprobada en la sesión 28/29 de Mayo de 1999 OMC, Revista del Consejo General de Colegios Médicos de España"
"fecha" => "2000"
"volumen" => "69"
"paginaInicial" => "28"
]
]
]
]
]
]
]
]
]
]
]
"idiomaDefecto" => "es"
"url" => "/02139111/0000001800000002/v1_201310251548/S0213911104718191/v1_201310251548/es/main.assets"
"Apartado" => array:4 [
"identificador" => "18705"
"tipo" => "SECCION"
"es" => array:2 [
"titulo" => "Originales"
"idiomaDefecto" => true
]
"idiomaDefecto" => "es"
]
"PDF" => "https://static.elsevier.es/multimedia/02139111/0000001800000002/v1_201310251548/S0213911104718191/v1_201310251548/es/main.pdf?idApp=WGSE&text.app=https://gacetasanitaria.org/"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911104718191?idApp=WGSE"
]
